November 2013 FDA Recall Ketoconazole by Fougera Pharmaceuticals Inc.
D-1044-2014 - Failed Impurities/Degradation Specifications
This Class III drug recall was voluntarily initiated by Fougera Pharmaceuticals Inc. on November 18, 2013 for the product Ketoconazole. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1044-2014
Failed Impurities/Degradation Specifications: Out-of-Specification degradant results.
11-18-2013
02-05-2014
31,122 tubes
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Fougera Pharmaceuticals Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide and Puerto Rico
05-09-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
KETOCONAZOLE CREAM, 2%, 30 gram tube, Rx only, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-30, UPC 3 0168-0099-30 9.
Batch or Lot Expiration Information
Lot# : 495P, Exp 07/14